市場調査レポート

商品コード

1390695

ペプチド治療薬市場レポート：タイプ別、メーカー別、合成技術別、投与経路別、用途別、地域別、2023年～2028年

Peptide Therapeutics Market Report by Type, Type of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2023-2028

出版日: 2023年11月24日 | 発行: IMARC

| ページ情報: 英文 149 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel (Single User License)

USD 2,499 391,743円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcelの印刷は一度のみ可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (5 User License)

USD 3,499 548,503円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcelの印刷は可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,499 705,263円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等の編集は可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

概要

世界のペプチド治療薬市場規模は2022年に392億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに661億米ドルに達し、2022年から2028年の間に9.10%の成長率（CAGR）を示すと予測しています。

ペプチドは、イオンチャネルやGタンパク質共役型受容体（GPCR）などの特定の細胞表面受容体に結合し、細胞内作用を引き起こす効率的かつ選択的なシグナル伝達分子です。製薬業界では、幅広い細胞を標的とし、その応答を操作できる新しい再生治療薬をデザインするために採用されています。これらの治療薬は、他の治療法よりも毒性が低く、比較的安全で、忍容性が高いです。その結果、がん、傷害、感染症、代謝障害、美容上の問題を管理するために、世界中の臨床現場で支持を集めています。

ペプチド治療薬市場の動向：

急性および慢性疾患の有病率の増加、医療施設へのアクセスの向上は、革新的な治療法を開発するためのペプチド需要にプラスの影響を与えている主要な要因の一つです。さらに、ペプチド治療は、皮膚の老化プロセスを遅らせるために美容外科手術に使用されています。このことは、個人の外見に対する意識の高まりや、若々しく健康な肌を保ちたいという願望と相まって、世界中で美容外科手術やペプチド治療薬の採用を後押ししています。これとは別に、注射回数を減らし、安定性やその他の物理的特性を改善する新規合成戦略のイントロダクションより、ペプチド治療薬は糖尿病患者への注射に広く使用されています。このことは、糖尿病の罹患率の増加や迅速かつ正確な治療法に対する嗜好の高まりと相まって、経口薬よりもペプチド治療薬の使用に影響を与えています。さらに、個別化治療や標的治療の新たな動向が、多機能ペプチドベースの材料に対する需要を喚起しています。これに加えて、自己免疫疾患や炎症性疾患を治療するための新規ペプチド治療薬を開発するための資金が増加しており、市場の見通しは明るいと予測されます。

本レポートで扱う主な質問

世界のペプチド治療薬市場の規模は？
2023年～2028年における世界のペプチド治療薬市場の予想成長率は？
世界のペプチド治療薬市場を牽引する主要因は何か？
COVID-19が世界のペプチド治療薬市場に与えた影響は？
ペプチド治療薬の世界市場のタイプ別区分は？
ペプチド治療薬の世界市場のメーカータイプ別区分は？
合成技術に基づくペプチド治療薬の世界市場内訳は？
投与経路に基づくペプチド治療薬の世界市場内訳は？
用途に基づく世界のペプチド治療薬市場の内訳は？
世界のペプチド治療薬市場における主要地域は？
世界のペプチド治療薬市場における主要プレイヤー/企業は？

北米
- 米国
  - 市場動向
  - 市場予測
- カナダ
  - 市場動向
  - 市場予測
アジア太平洋
- 中国
  - 市場動向
  - 市場予測
- 日本
  - 市場動向
  - 市場予測
- インド
  - 市場動向
  - 市場予測
- 韓国
  - 市場動向
  - 市場予測
- オーストラリア
  - 市場動向
  - 市場予測
- インドネシア
  - 市場動向
  - 市場予測
- その他
  - 市場動向
  - 市場予測
欧州
- ドイツ
  - 市場動向
  - 市場予測
- フランス
  - 市場動向
  - 市場予測
- 英国
  - 市場動向
  - 市場予測
- イタリア
  - 市場動向
  - 市場予測
- スペイン
  - 市場動向
  - 市場予測
- ロシア
  - 市場動向
  - 市場予測
- その他
  - 市場動向
  - 市場予測
ラテンアメリカ
- ブラジル
  - 市場動向
  - 市場予測
- メキシコ
  - 市場動向
  - 市場予測
- その他
  - 市場動向
  - 市場予測
中東・アフリカ
- 市場動向
- 市場内訳：国別
- 市場予測

第12章 SWOT分析

概要
強み
弱み
機会
脅威

第13章バリューチェーン分析

第14章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第15章価格分析

第16章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Amgen Inc.
- Apitope International NV
- Arch Biopartners Inc.
- AstraZeneca plc
- Circle Pharma Inc.
- Corden Pharma GmbH
- F. Hoffmann-La Roche AG
- Ipsen Group
- Lonza Group AG
- Novo Nordisk A/S
- Pfizer Inc.
- Teva Pharmaceuticals Industries Ltd.
- Zealand Pharma A/S

図表

List of Figures

Figure 1: Global: Peptide Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Peptide Therapeutics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Peptide Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Peptide Therapeutics Market: Breakup by Type (in %), 2022
Figure 5: Global: Peptide Therapeutics Market: Breakup by Type of Manufacturer (in %), 2022
Figure 6: Global: Peptide Therapeutics Market: Breakup by Synthesis Technology (in %), 2022
Figure 7: Global: Peptide Therapeutics Market: Breakup by Routes of Administration (in %), 2022
Figure 8: Global: Peptide Therapeutics Market: Breakup by Application (in %), 2022
Figure 9: Global: Peptide Therapeutics Market: Breakup by Region (in %), 2022
Figure 10: Global: Peptide Therapeutics (Innovative) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Peptide Therapeutics (Innovative) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Peptide Therapeutics (Generic) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Peptide Therapeutics (Generic) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Peptide Therapeutics (Outsourced) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Peptide Therapeutics (Outsourced) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Peptide Therapeutics (In-house) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Peptide Therapeutics (In-house) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Peptide Therapeutics (Hybrid Technology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Peptide Therapeutics (Hybrid Technology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Peptide Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Peptide Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Peptide Therapeutics (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Peptide Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Peptide Therapeutics (Other Routes of Administration) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Peptide Therapeutics (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Peptide Therapeutics (Neurological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Peptide Therapeutics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Peptide Therapeutics (Metabolic Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Peptide Therapeutics (Metabolic Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Peptide Therapeutics (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Peptide Therapeutics (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Peptide Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Peptide Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: North America: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: North America: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: United States: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: United States: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Canada: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Canada: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Asia-Pacific: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Asia-Pacific: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: China: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: China: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Japan: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Japan: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: India: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: India: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: South Korea: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: South Korea: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Australia: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Australia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Indonesia: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Indonesia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Europe: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Europe: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Germany: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Germany: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: France: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: France: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: United Kingdom: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: United Kingdom: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Italy: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Italy: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Spain: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Spain: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Russia: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Russia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Latin America: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Latin America: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Brazil: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Brazil: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Mexico: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Mexico: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Middle East and Africa: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Middle East and Africa: Peptide Therapeutics Market: Breakup by Country (in %), 2022
Figure 88: Middle East and Africa: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Global: Peptide Therapeutics Industry: SWOT Analysis
Figure 90: Global: Peptide Therapeutics Industry: Value Chain Analysis
Figure 91: Global: Peptide Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Peptide Therapeutics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Peptide Therapeutics Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Peptide Therapeutics Market Forecast: Breakup by Type of Manufacturer (in Million US$), 2023-2028
Table 4: Global: Peptide Therapeutics Market Forecast: Breakup by Synthesis Technology (in Million US$), 2023-2028
Table 5: Global: Peptide Therapeutics Market Forecast: Breakup by Routes of Administration (in Million US$), 2023-2028
Table 6: Global: Peptide Therapeutics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 7: Global: Peptide Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Peptide Therapeutics Market: Competitive Structure
Table 9: Global: Peptide Therapeutics Market: Key Players

Product Code: SR112023A4510

Abstract

The global peptide therapeutics market size reached US$ 39.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 66.1 Billion by 2028, exhibiting a growth rate (CAGR) of 9.10% during 2022-2028.

Peptides are efficacious and selective signaling molecules that bind to specific cell surface receptors, such as ion channels and G protein-coupled receptors (GPCRs) and trigger intracellular effects. They are employed in the pharmaceutical industry to design novel regenerative therapeutics that can target a wide range of cells and manipulate their responses. These therapeutics are less toxic, relatively safe, and well-tolerated than other treatment options. As a result, they are gaining traction in clinical practices worldwide to manage cancer, injuries, infectious diseases, metabolic disorders, and aesthetic concerns.

Peptide Therapeutics Market Trends:

The growing prevalence of acute and chronic diseases, along with the rising access to medical facilities, represents one of the leading factors positively influencing the demand for peptides to develop innovative therapies. Moreover, peptides therapies are used in cosmeceutical surgeries to slow down the process of skin aging. This, coupled with the increasing consciousness among individuals about physical appearance and the desire to retain young and healthy skin, is driving the adoption of cosmetic surgeries and peptide therapeutics around the world. Apart from this, with the introduction of novel synthetic strategies that reduce injection frequency and improve stability and other physical properties, peptide therapeutics are widely being used in injections for diabetic patients. This, in confluence with the increasing incidence of diabetes and the growing preference for quick and precise treatment methods, is influencing the use of peptide therapeutics over oral medications. Furthermore, the emerging trend of personalized and targeted treatments is catalyzing the demand for multifunctional peptide-based materials. This, along with the rising funding to develop novel peptide therapeutics for treating autoimmune and inflammatory diseases, is projected to create a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global peptide therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, type of manufacturer, synthesis technology, routes of administration and application.

Breakup by Type:

Innovative

Generic

Breakup by Type of Manufacturer:

Outsourced

In-house

Breakup by Synthesis Technology:

Solid Phase Peptide Synthesis

Liquid Phase Peptide Synthesis

Hybrid Technology

Breakup by Routes of Administration:

Parenteral

Oral

Others

Breakup by Application:

Gastrointestinal Disorders

Neurological Disorders

Metabolic Disorders

Cancer

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Apitope International NV, Arch Biopartners Inc., AstraZeneca plc, Circle Pharma Inc., Corden Pharma GmbH, F. Hoffmann-La Roche AG, Ipsen Group, Lonza Group AG, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceuticals Industries Ltd. and Zealand Pharma A/S.

Key Questions Answered in This Report

1. How big is the global peptide therapeutics market?
2. What is the expected growth rate of the global peptide therapeutics market during 2023-2028?
3. What are the key factors driving the global peptide therapeutics market?
4. What has been the impact of COVID-19 on the global peptide therapeutics market?
5. What is the breakup of the global peptide therapeutics market based on the type?
6. What is the breakup of the global peptide therapeutics market based on the type of manufacturer?
7. What is the breakup of the global peptide therapeutics market based on the synthesis technology?
8. What is the breakup of the global peptide therapeutics market based on the routes of administration?
9. What is the breakup of the global peptide therapeutics market based on the application?
10. What are the key regions in the global peptide therapeutics market?
11. Who are the key players/companies in the global peptide therapeutics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Peptide Therapeutics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Innovative
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Generic
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Type of Manufacturer

7.1 Outsourced
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 In-house
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Synthesis Technology

8.1 Solid Phase Peptide Synthesis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Liquid Phase Peptide Synthesis
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Hybrid Technology
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Routes of Administration

9.1 Parenteral
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Oral
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Application

10.1 Gastrointestinal Disorders
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Neurological Disorders
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Metabolic Disorders
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
10.4 Cancer
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
10.5 Others
- 10.5.1 Market Trends
- 10.5.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia-Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 Amgen Inc.
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
  - 16.3.1.3 Financials
  - 16.3.1.4 SWOT Analysis
- 16.3.2 Apitope International NV
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
- 16.3.3 Arch Biopartners Inc.
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
  - 16.3.3.3 Financials
- 16.3.4 AstraZeneca plc
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
  - 16.3.4.3 Financials
  - 16.3.4.4 SWOT Analysis
- 16.3.5 Circle Pharma Inc.
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
- 16.3.6 Corden Pharma GmbH
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
- 16.3.7 F. Hoffmann-La Roche AG
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
  - 16.3.7.3 SWOT Analysis
- 16.3.8 Ipsen Group
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
  - 16.3.8.3 Financials
  - 16.3.8.4 SWOT Analysis
- 16.3.9 Lonza Group AG
  - 16.3.9.1 Company Overview
  - 16.3.9.2 Product Portfolio
  - 16.3.9.3 Financials
  - 16.3.9.4 SWOT Analysis
- 16.3.10 Novo Nordisk A/S
  - 16.3.10.1 Company Overview
  - 16.3.10.2 Product Portfolio
  - 16.3.10.3 Financials
  - 16.3.10.4 SWOT Analysis
- 16.3.11 Pfizer Inc.
  - 16.3.11.1 Company Overview
  - 16.3.11.2 Product Portfolio
  - 16.3.11.3 Financials
  - 16.3.11.4 SWOT Analysis
- 16.3.12 Teva Pharmaceuticals Industries Ltd.
  - 16.3.12.1 Company Overview
  - 16.3.12.2 Product Portfolio
  - 16.3.12.3 Financials
  - 16.3.12.4 SWOT Analysis
- 16.3.13 Zealand Pharma A/S
  - 16.3.13.1 Company Overview
  - 16.3.13.2 Product Portfolio
  - 16.3.13.3 Financials

ペプチド治療薬市場レポート：タイプ別、メーカー別、合成技術別、投与経路別、用途別、地域別、2023年～2028年

Peptide Therapeutics Market Report by Type, Type of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2023-2028

概要

ペプチド治療薬市場の動向：

本レポートで扱う主な質問

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のペプチド治療薬市場

第6章 市場内訳：タイプ別

第7章 市場内訳：メーカータイプ別

第8章 市場内訳：合成技術別

第9章 市場内訳：投与経路別

第10章 市場内訳：用途別

第11章 市場内訳：地域別

第12章 SWOT分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 価格分析

第16章 競合情勢

List of Figures

List of Tables

Abstract

Peptide Therapeutics Market Trends:

Key Market Segmentation:

Breakup by Type:

Breakup by Type of Manufacturer:

Breakup by Synthesis Technology:

Breakup by Routes of Administration:

Breakup by Application:

Breakup by Region:

Competitive Landscape:

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Peptide Therapeutics Market

6 Market Breakup by Type

7 Market Breakup by Type of Manufacturer

8 Market Breakup by Synthesis Technology

9 Market Breakup by Routes of Administration

10 Market Breakup by Application

11 Market Breakup by Region

12 SWOT Analysis

13 Value Chain Analysis

14 Porters Five Forces Analysis

15 Price Analysis

16 Competitive Landscape

第1章序文

第2章調査範囲と調査手法

第3章エグゼクティブサマリー

第4章イントロダクション

第5章世界のペプチド治療薬市場

第6章市場内訳：タイプ別

第7章市場内訳：メーカータイプ別

第8章市場内訳：合成技術別

第9章市場内訳：投与経路別

第10章市場内訳：用途別

第11章市場内訳：地域別

第13章バリューチェーン分析

第14章ポーターのファイブフォース分析

第15章価格分析

第16章競合情勢